Doctors in Northern Ireland welcome HPV vaccination programme

Doctors in Northern Ireland have welcomed the Chief Medical Officer's announcement today, Wednesday 3 September 2008, to offer vaccination against the Human Papillomavirus (HPV) to all 12-13 year old girls in Northern Ireland. HPV is the virus which can lead to the development of cancer, in particular cervical cancer.

Commenting on the announcement, BMA(NI) Public Health Chairman, Dr Colin Hamilton, said: "We are very glad to have the opportunity to prevent the impact of cervical cancer on future generations. It is the second most common cancer of women worldwide.

"For many years to come though the current cervical cancer screening programme will be essential and we would encourage all women to attend when invited to do so."

Dr Brian Dunn, Chairman of BMA(NI's) General Practitioners Committee also welcomed the announcement. "This is an important public health measure", he said, "and we would encourage all girls in this age group to take up the offer of vaccination. We are also pleased to see that this programme will be extended via the GP network to the wider teenage age group in Northern Ireland."

http://www.bma.org.uk

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths